https://www.businesswire.com/news/home/20250108129909/en/BioSkryb-Genomics-Launches-ResolveSEQ-MRD-A-Next-Generation-Measurable-Residual-Disease-MRD-Discovery-Solution
BioSkryb Genomics Launches ResolveSEQ MRD: A Next-Generation Measurable Residual Disease (MRD)...
BioSkryb launches ResolveSEQ MRD, an innovative service offering designed to empower further classification and characterization of MRD cells.
next generationgenomicslaunchesmrd